CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

Zimmermann, M., Murina, O., Reijns, M.A., Agathanggelou, A., Challis, R., Tarnauskaitė, �., Muir, M., Fluteau, A., Aregger, M., McEwan, A., Yuan, W., Clarke, M., Lambros, M.B., Paneesha, S., Moss, P., Chandrashekhar, M., Angers, S., Moffat, J., Brunton, V.G., &amp; Hart, T. (2018). CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. <em>Nature</em>. https://doi.org/10.1038/s41586-018-0291-z

Zimmermann M, Murina O, Reijns MA, Agathanggelou A, Challis R, Tarnauskaitė �, et al. CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. Nature. 2018. doi:10.1038/s41586-018-0291-z.

@unpublished{michal2018CRISPR, title = {CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions}, author = {Michal Zimmermann and Olga Murina and Martin A.M. Reijns and Angelo Agathanggelou and Rachel Challis and Žygimantė Tarnauskaitė and Morwenna Muir and Adeline Fluteau and Michael Aregger and Andrea McEwan and Wei Yuan and Matthew Clarke and Maryou B. Lambros and Shankara Paneesha and Paul Moss and Megha Chandrashekhar and Stéphane Angers and Jason Moffat and Valerie G. Brunton and Traver Hart and Johann S. de Bono and Tatjana Stanković and Andrew P. Jackson and Daniel Durocher}, journal = {Nature}, year = {2018}, doi = {10.1038/s41586-018-0291-z}, }